Griffin Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.56M | Sell |
61,710
-8
| -0% | -$459 | 0.37% | 66 |
|
|
2026
Q1 | $3.74M | Sell |
61,718
-6,730
| -10% | -$392K | 0.42% | 66 |
|
|
2025
Q4 | $3.69M | Buy |
68,448
+1,222
| +2% | +$58.8K | 0.4% | 63 |
|
|
2025
Q3 | $3.03M | Sell |
67,226
-4,641
| -6% | -$217K | 0.34% | 76 |
|
|
2025
Q2 | $3.33M | Sell |
71,867
-306
| -0.4% | -$15K | 0.39% | 72 |
|
|
2025
Q1 | $4.4M | Sell |
72,173
-7,441
| -9% | -$434K | 0.54% | 52 |
|
|
2024
Q4 | $4.5M | Buy |
79,614
+563
| +0.7% | +$31.5K | 0.53% | 52 |
|
|
2024
Q3 | $4.09M | Sell |
79,051
-3,102
| -4% | -$146K | 0.46% | 60 |
|
|
2024
Q2 | $3.41M | Sell |
82,153
-5,497
| -6% | -$246K | 0.4% | 65 |
|
|
2024
Q1 | $4.75M | Sell |
87,650
-43
| -0% | -$2.19K | 0.57% | 51 |
|
|
2023
Q4 | $4.5M | Sell |
87,693
-20,170
| -19% | -$1.06M | 0.57% | 51 |
|
|
2023
Q3 | $6.26M | Sell |
107,863
-6,745
| -6% | -$413K | 0.89% | 36 |
|
|
2023
Q2 | $7.33M | Buy |
114,608
+13,566
| +13% | +$910K | 0.99% | 30 |
|
|
2023
Q1 | $7M | Sell |
101,042
-108
| -0.1% | -$7.62K | 0.98% | 30 |
|
|
2022
Q4 | $7.28M | Buy |
101,150
+684
| +0.7% | +$51.6K | 1.1% | 22 |
|
|
2022
Q3 | $7.14M | Sell |
100,466
-233
| -0.2% | -$16.9K | 1.19% | 22 |
|
|
2022
Q2 | $7.75M | Sell |
100,699
-5,964
| -6% | -$454K | 1.24% | 18 |
|
|
2022
Q1 | $7.79M | Sell |
106,663
-3,656
| -3% | -$245K | 1.01% | 24 |
|
|
2021
Q4 | $6.88M | Sell |
110,319
-17,471
| -14% | -$1.02M | 0.85% | 33 |
|
|
2021
Q3 | $7.56M | Buy |
127,790
+6,587
| +5% | +$434K | 0.97% | 28 |
|
|
2021
Q2 | $8.1M | Buy |
121,203
+427
| +0.4% | +$27.8K | 0.98% | 28 |
|
|
2021
Q1 | $7.63M | Sell |
120,776
-6,849
| -5% | -$426K | 0.97% | 29 |
|
|
2020
Q4 | $7.92M | Buy |
127,625
+6,822
| +6% | +$419K | 1.05% | 24 |
|
|
2020
Q3 | $7.28M | Sell |
120,803
-2,499
| -2% | -$150K | 1.12% | 23 |
|
|
2020
Q2 | $7.25M | Sell |
123,302
-1,524
| -1% | -$91.2K | 1.16% | 16 |
|
|
2020
Q1 | $6.96M | Sell |
124,826
-198
| -0.2% | -$12.1K | 1.32% | 16 |
|
|
2019
Q4 | $8.03M | Buy |
125,024
+4,202
| +3% | +$241K | 1.12% | 17 |
|
|
2019
Q3 | $6.13M | Sell |
120,822
-93,500
| -44% | -$4.39M | 0.95% | 30 |
|
|
2019
Q2 | $9.72M | Buy |
214,322
+2,845
| +1% | +$133K | 1.24% | 11 |
|
|
2019
Q1 | $10.1M | Buy |
211,477
+10,723
| +5% | +$534K | 1.43% | 11 |
|
|
2018
Q4 | $10.4M | Buy |
200,754
+3,337
| +2% | +$179K | 1.76% | 9 |
|
|
2018
Q3 | $12.3M | Buy |
197,417
+2,916
| +1% | +$173K | 1.8% | 8 |
|
|
2018
Q2 | $10.8M | Buy |
194,501
+7,494
| +4% | +$405K | 1.95% | 9 |
|
|
2018
Q1 | $11.8M | Buy |
187,007
+1,854
| +1% | +$119K | 2.15% | 6 |
|
|
2017
Q4 | $11.3M | Buy |
185,153
+8,230
| +5% | +$515K | 2.02% | 7 |
|
|
2017
Q3 | $11.3M | Buy |
176,923
+6,354
| +4% | +$371K | 2.04% | 7 |
|
|
2017
Q2 | $9.5M | Buy |
+170,569
| New | +$9.28M | 2.54% | 5 |
|
|
2015
Q4 | $4.18M | Sell |
60,827
-7,794
| -11% | -$515K | 1.76% | 24 |
|
|
2015
Q3 | $4.06M | Sell |
68,621
-3,529
| -5% | -$224K | 1.69% | 26 |
|
|
2015
Q2 | $4.8M | Sell |
72,150
-11,072
| -13% | -$730K | 1.84% | 25 |
|
|
2015
Q1 | $5.37M | Sell |
83,222
-4,433
| -5% | -$278K | 1.56% | 26 |
|
|
2014
Q4 | $5.17M | Sell |
87,655
-648
| -0.7% | -$36.5K | 1.38% | 30 |
|
|
2014
Q3 | $4.52M | Buy |
88,303
+5,385
| +6% | +$269K | 1.35% | 29 |
|
|
2014
Q2 | $4.02M | Sell |
82,918
-774
| -0.9% | -$38.1K | 1.26% | 35 |
|
|
2014
Q1 | $4.35M | Sell |
83,692
-4,953
| -6% | -$264K | 1.41% | 30 |
|
|
2013
Q4 | $4.71M | Sell |
88,645
-11,580
| -12% | -$590K | 1.52% | 28 |
|
|
2013
Q3 | $4.64M | Buy |
100,225
+1,102
| +1% | +$48.4K | 1.52% | 27 |
|
|
2013
Q2 | $4.43M | Buy |
+99,123
| New | +$4.3M | 1.6% | 23 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Griffin Asset Management's BMY Position: Q2 2026 in Review
Griffin Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.01% in Q2 2026, selling an estimated $459 and leaving 61,710 shares worth $3.56M. The position accounts for 0.37% of the portfolio, ranked #66.
Griffin Asset Management first reported a position in BMY in Q2 2013 and has held it in 48 quarters since. The position peaked at $12.3M in Q3 2018. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Griffin Asset Management held 61,710 shares of Bristol-Myers Squibb worth $3.56M as of Q2 2026.
- Griffin Asset Management sold 8 Bristol-Myers Squibb shares in Q2 2026, an estimated $459.
- Bristol-Myers Squibb made up 0.37% of Griffin Asset Management's portfolio in Q2 2026, its #66 holding.
- Griffin Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 48 quarters since.
- Griffin Asset Management's Bristol-Myers Squibb position peaked at $12.3M in Q3 2018.
- 831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Griffin Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.